Stock listing

NASDAQ:ADMS Adamas Pharmaceuticals Inc Stock

Follow Adamas Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:ADMS

$8.22 USD

Close on Nov 24, 2021 · No longer trades

Apr 10, 2014 to last close -41.3% · weekly closes, Apr 10, 2014 – Nov 24, 2021
Lowest – highest close
$1.99 – $42.65 USDSince Apr 10, 2014 · lowest Mar 18, 2020 · highest Jan 23, 2018

Delisted NASDAQ:ADMS no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:ADMS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Mardi C. Dier
Other companies: Madrigal Pharmaceuticals, Inc. (EVP and CFO · Since at least Mar 11, 2024); Prelude Therapeutics Incorporated (Director · Since at least Sep 24, 2020); ORIC Pharmaceuticals, Inc. (Board Member · Since at least Apr 23, 2020); Acelyrin, Inc. (CFO and CBO · May 4, 2023 – May 9, 2023 · Past); Ultragenyx Pharmaceutical Inc. (CFO & Executive Vice President · Oct 12, 2020 – Oct 14, 2022 · Past); Portola Pharmaceuticals Inc (EVP and CFO · May 21, 2013 – Jul 2, 2020 · Past)
Director · Oct 10, 2017 – Jun 2, 2021 · Past
Rajiv Patni
Other companies: Septerna, Inc. (Chief Medical Officer · Since at least Aug 24, 2026); BioXcel Therapeutics, Inc. (Director · Since at least Jan 15, 2025); Quince Therapeutics, Inc. (Director · Since at least Feb 15, 2024); Reata Pharmaceuticals Inc (EVP, Chief R&D Officer · Jun 12, 2023 – Sep 26, 2023 · Past); Portola Pharmaceuticals Inc (EVP, CMO · Feb 3, 2020 – Jul 2, 2020 · Past); Ocera Therapeutics Inc (Chief Development Officer · Sep 2, 2014 – May 7, 2015 · Past)
Chief Medical Officer · Jun 8, 2015 – Apr 8, 2019 · Past
Sara Grootwassink Lewis
Other companies: Freeport-McMoRan, Inc. (Director · Since at least Aug 2, 2021); Healthpeak Properties, Inc. (Director · Since at least Nov 5, 2019); Weyerhaeuser Company (Director · Since at least Feb 19, 2016); Plum Creek Timber Company. Inc (Director · Nov 5, 2013 – Feb 19, 2016 · Past); CapitalSource Inc (Director · Apr 26, 2012 – Apr 7, 2014 · Past)
Director · Apr 9, 2014 – May 14, 2015 · Past
Jennifer J. Rhodes
Other companies: ACADIA Pharmaceuticals Inc. (Chief Legal Officer and Secretary · Since at least Feb 6, 2024); Elicio Therapeutics, Inc. (See Remarks · Feb 4, 2021 – Mar 2, 2022 · Past); Medivation Inc (GC & Corporate Secretary · Mar 26, 2013 – Mar 16, 2015 · Past)
CBO, GC & Compliance Officer · Apr 11, 2016 – Jun 20, 2019 · Past
Richard King
Other companies: Spruce Biosciences, Inc. (Chief Executive Officer, Director · Oct 8, 2020 – Jun 30, 2021 · Past); Talphera, Inc. (Director · Feb 10, 2011 – Mar 2, 2014 · Past); Kos Pharmaceuticals Inc (EVP, Commercial Operations · Jan 3, 2006 – Mar 10, 2006 · Past)
Chief Operating Officer · Apr 28, 2017 – Jun 21, 2018 · Past
Spyros Papapetropoulos
Other companies: Neuphoria Therapeutics Inc. (President and CEO, Director · Since at least Jul 1, 2024); Lipocine Inc. (Director · Since at least Apr 11, 2022); Vigil Neuroscience Inc (Chief Medical Officer · Jan 6, 2022 – Nov 18, 2022 · Past)
Director · Nov 22, 2020 – Nov 24, 2021 · Past
Anna Richo
Other companies: Illumina, Inc. (Director · Since at least May 16, 2024); Exelon Corporation (Independent Director since 2023 · Since at least Aug 1, 2023)
Director · Aug 29, 2020 – Nov 24, 2021 · Past
David L. Mahoney
Other companies: Corcept Therapeutics Incorporated (Director · Since at least Nov 16, 2017); Gen Digital Inc. (Director · May 17, 2018 – May 14, 2019 · Past)
Director · Nov 29, 2017 – Nov 24, 2021 · Past
William W Ericson
Other companies: Pacific Biosciences of California, Inc. (Director · Since at least Oct 26, 2010); Rocket Fuel Inc (Director · Sep 19, 2013 – Sep 6, 2017 · Past)
Director · Apr 9, 2014 – Nov 24, 2021 · Past
Alfred G Merriweather
Other companies: Celera CORP (SVP, Chief Financial Officer · Dec 20, 2010 – May 17, 2011 · Past)
Chief Financial Officer · Jun 29, 2017 – Sep 20, 2019 · Past
All 16 people
PersonSeat
Chris Prentiss
Other companies: MannKind Corporation (Chief Financial Officer · Since at least Apr 22, 2024)
Chief Financial Officer · Sep 15, 2017 – Nov 24, 2021 · Past
John A MacPhee
Other companies: Par Pharmaceutical Companies Inc (EVP, Pres-Strativa · Jan 9, 2006 – Jan 11, 2011 · Past)
Director · Apr 9, 2014 – Nov 24, 2021 · Past
Grace ShinGeneral Counsel · Dec 1, 2014 – Dec 1, 2014 · Past
Gregory T WentChief Executive Officer, Director · Jun 15, 2016 – Apr 8, 2019 · Past
Ivan M LieberburgDirector · Apr 9, 2014 – Jun 3, 2020 · Past
Natalie McClureSVP, Product Development · Apr 18, 2016 – Apr 18, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Adamas Pharmaceuticals Inc.